This topic contains a solution. Click here to go to the answer

Author Question: The molecular weight of carbon dioxide is 44.0 g/mol. What is the internal energy in 3.00 kg of ... (Read 68 times)

bclement10

  • Hero Member
  • *****
  • Posts: 560
The molecular weight of carbon dioxide is 44.0 g/mol. What is the internal energy in 3.00 kg of carbon dioxide at 300 K? As an approximation, treat the carbon dioxide gas as if it was monatomic.
 
  A) 2.55  105 J
  B) 1.70  105 J
  C) 2.55  104 J
  D) 1.70  104 J
  E) 1.70  106 J

Question 2

A satellite is in a circular parking orbit 6.98  106 m from the center of Earth. To initiate a Hohmann transfer, a rocket gives it an accelerating thrust so that its speed is increased to 8300 m/s.
 
  How far from the center of Earth will the satellite be when it reaches its apogee? The mass of Earth is 5.97  1024 kg and G = 6.67 x 10-11 Nm2/kg2. A) 3.12  107 m
  B) 2.48  107 m
  C) 1.06  107 m
  D) 6.73  107 m
  E) 4.75  107 m



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

TheNamesImani

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

A

Answer to Question 2

D




bclement10

  • Member
  • Posts: 560
Reply 2 on: Jul 29, 2018
Gracias!


31809pancho

  • Member
  • Posts: 317
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

Multiple sclerosis is a condition wherein the body's nervous system is weakened by an autoimmune reaction that attacks the myelin sheaths of neurons.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

For a complete list of videos, visit our video library